• Cardiex raises $4.1 million through fully underwritten, non-renounceable pro-rata entitlement offer
• Combined with recent institutional placement, company has now received $6.5 million in funds and commitments
• Offer well supported by eligible shareholders with 50.3% take-up

Cardiex Limited (ASX: CDX) ('Cardiex' or 'the Company') has announced the results of its fully underwritten, non-renounceable pro-rata entitlement offer ('Entitlement Offer') to raise approximately $4.1 million. The Entitlement Offer was well supported by eligible shareholders, who applied for approximately 49,389,383 new shares, along with an additional 1,717,515 new shares under the Top-Up Offer, representing a total take-up of approximately 50.3% of the Entitlement Offer. The balance of the Entitlement Offer was allocated to the underwriter and sub-underwriters in accordance with the underwriting arrangements. C2 Ventures (a company jointly owned by Directors Niall Cairns and Craig Cooper), as well as with Directors and other entities associated with Directors of the Company took up their entitlements totaling 33,753,338 new shares, representing a value of $1,350,133.08. The Entitlement Offer was fully underwritten by Blackpeak Capital Pty Ltd, which entered into sub-underwriting agreements with a number of parties including C2 Ventures and certain of its associates. These sub-underwriters took up their full entitlements, totaling 50,409,547 new shares, representing a value of $2,016,381.88. The funds raised from the Entitlement Offer, combined with the completion of the Institutional Placement announced on 30 May 2025, provide the Company with a total of $6.5 million (before costs).